 |
市場調查報告書
商品編碼
1181757
葡萄膜炎治療市場：按治療類型、按疾病類型、按分銷渠道、按地區 - 規模、份額、展望、機會分析，2022-2030 年Uveitis Treatment Market, by Treatment Type, by Disease type, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
價格
簡介目錄
葡萄膜炎是眼睛葡萄膜的炎症。 葡萄膜是眼睛的中間層，由三部分組成：虹膜、睫狀體和脈絡膜。 葡萄膜炎是由多種因素引起的，包括炎症性疾病、眼外傷、病毒、細菌和真菌等微生物感染，以及接觸強酸和殺蟲劑等有毒化學品。 然而，在許多情況下，這種症狀的原因仍然未知。 此外，已發現屬於 20-50 歲年齡組的人受到影響。 根據葡萄膜發炎的部位分為三種類型，包括前葡萄膜炎，這是最常見的虹膜炎症。
市場動態
預計在預測期內，市場參與者推出更多產品將推動全球葡萄膜炎治療市場。 例如，2022 年 2 月 7 日，總部位於佐治亞州、專門從事眼科處方藥商業化和開發的生物製藥公司 Alimera Sciences 在西班牙宣布推出用於葡萄膜炎的 ILUVIEN（fluocino）和 Ronacetonide（玻璃體內註射）。 ILUVIEN在歐洲獲批用於預防因慢性糖尿病性黃斑水腫（DME）和後段非感染性葡萄膜炎（NIPU）引起的視力喪失復發，目前治療被認為是不充分的。它是一種緩釋眼內留置注射劑. ILUVIEN 是一個為期 36 個月的亞微克氟輕鬆丙酮療程，這是一種皮質類固醇，可幫助患者更長時間地保持視力。
這項研究的主要特點
- 本報告對全球葡萄膜炎藥物市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。
- 它揭示了不同細分市場的潛在收入機會，並描述了該市場具有吸引力的投資建議矩陣。
- 它還提供了有關市場驅動因素、制約因素、機會、新產品發布和批准、市場趨勢、區域前景以及主要參與者採用的競爭戰略的重要見解。
- 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數介紹全球葡萄膜炎治療市場主要參與者的概況。
- 本研究涵蓋的主要公司包括 AbbVie、Novartis AG、Bausch Health Companies Inc.、Galapagos NV、EyePoint Pharmaceuticals, Inc.、Clearside Biomedical、Tarsier Pharma Ltd、Santen Pharmaceutical Co., Ltd.、Bausch & Lomb Incorporated, Sanofi and Regeneron Pharmaceuticals, Inc., Alimera Sciences
- 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
- 《全球葡萄膜炎治療藥物市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
- 利益相關者可以通過用於分析全球葡萄膜炎治療市場的各種戰略矩陣來促進決策制定。
內容
第 1 章目的和先決條件
- 調查目的
- 先決條件
- 縮寫說明
第二章市場展望
- 報告內容
- 市場定義和範圍
- 執行摘要
- 市場概況：按治療類型分類
- 按疾病類型劃分的市場概況
- 市場概況：按銷售渠道
- 市場概況：按地區
- 連貫機會圖 (COM)
第3章市場動態、規律及趨勢分析
- 市場動態
- 司機
- 約束因素
- 市場機會
- 影響分析
- 市場趨勢
- 近期趨勢
- 收購和合作場景
- 技術概述
- 監管場景
- 管道分析
- 害蟲分析
第 4 章全球葡萄膜炎藥物市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 總體影響
- 對供需的影響
- COVID-19 對市場的影響
第 5 章全球葡萄膜炎藥物市場：按治療類型分類，2017-2030
- 腎上腺皮質類固醇
- 免疫抑製劑
- 單克隆抗體
- Cycloprenetic 藥物
- 抗生素
- 抗病毒劑
- 抗真菌劑
- 抗生素
- 止痛藥
第 6 章按疾病類型劃分的葡萄膜炎藥物全球市場，2017-2030
- 前葡萄膜炎
- 後葡萄膜炎
- 中間葡萄膜炎
- 全葡萄膜炎
第 7 章全球葡萄膜炎藥物市場：按分銷渠道，2017-2030
- 醫院藥房
- 零售藥房
- 在線藥店
- 藥店
第 8 章 2017-2030 年按地區分列的全球葡萄膜炎藥物市場
- 北美
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地區
- 歐洲
- 英國
- 德國
- 意大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 東盟
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東
- 海灣合作委員會
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中非
- 南非
第9章競爭格局
- AbbVie
- Novartis AG
- Bausch Health Companies Inc.
- Galapagos NV
- EyePoint Pharmaceuticals, Inc.
- Clearside Biomedical
- Tarsier Pharma Ltd
- Santen Pharmaceutical Co., Ltd.
- Bausch & Lomb Incorporated
- Sanofi
- Regeneron Pharmaceuticals, Inc.
- Alimera Sciences
第 10 章
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI1094
Uveitis refers to inflammation caused in the uvea of the eye. A uvea is the middle layer of the eye that consists of three components namely iris, cilliary body, and the choroid. Uveitis is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides. However, in many cases the cause of this condition remains unknown. It is also found to be effecting people belonging to the age group of 20-50 years. The condition is classified based on the location of inflammation in the uvea and is categorized in three types including anterior uveitis that causes inflammation in the iris and is the most commonly encountered type.
Market Dynamics
Increasing product launches by market players is expected to drive the global uveitis treatment market over the forecast period. For instance, in February 7, 2022, Alimera Sciences which is a biopharmaceutical company based in Georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, has announced that it has announced Launch of ILUVIEN (fluocinolone acetonide intravitreal implant) for Uveitis in Spain. ILUVIEN is a sustained release intravitreal implant approved for use in Europe to treat vision loss brought on by chronic diabetic macular edema (DME), which is thought to be under responsive to current treatments, as well as to prevent relapse in cases of recurrent non-infectious uveitis affecting the posterior segment of the eye (NIPU). ILUVIEN is made to deliver sub-microgram quantities of the corticosteroid fluocinolone acetonide for 36 months, which helps patients preserve their vision for longer between treatments.
Key features of the study:
- This report provides in-depth analysis of the global uveitis treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global uveitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AbbVie, Novartis AG, Bausch Health Companies Inc., Galapagos NV, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Tarsier Pharma Ltd, Santen Pharmaceutical Co., Ltd., Bausch & Lomb Incorporated, Sanofi and Regeneron Pharmaceuticals, Inc., Alimera Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global uveitis treatment market
Detailed Segmentation:
- Global Uveitis Treatment Market, By Treatment Type:
- Corticosteroids
- Immunosuppressant
- Monoclonal Antibodies
- Cycloplegic Agents
- Antibiotics
- Antivirals
- Antifungal
- Analgesics
- Global Uveitis Treatment Market, By Disease Type:
- Anterior Uveitis
- Posterior Uveitis
- Intermediate Uveitis
- Pan uveitis
- Global Uveitis Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Global Uveitis Treatment Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- AbbVie
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Bausch Health Companies Inc.
- Galapagos NV
- EyePoint Pharmaceuticals, Inc.
- Clearside Biomedical
- Tarsier Pharma Ltd
- Santen Pharmaceutical Co., Ltd.
- Bausch & Lomb Incorporated
- Sanofi
- Regeneron Pharmaceuticals, Inc.
- Alimera Sciences
- AbbVie
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pipeline Analysis
- PEST Analysis
4. Global Uveitis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Uveitis Treatment Market, By Treatment Type, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Immunosuppressant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Cycloplegic Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antivirals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antifungal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Uveitis Treatment Market, By Disease Type, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Anterior Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Posterior Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Intermediate Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Pan uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Uveitis Treatment Market, By Distribution Channel, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Drug Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global Uveitis Treatment Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- AbbVie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Galapagos NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- EyePoint Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Clearside Biomedical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Tarsier Pharma Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Santen Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch & Lomb Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alimera Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
